LS Investment Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

LS Investment Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,134	Closed	-$128K	–	1892
2017 Q3	$128K	Hold	1,134	–	–	0.01%	1082
2017 Q2	$127K	Hold	1,134	–	–	0.01%	1063
2017 Q1	$132K	Hold	1,134	–	–	0.01%	1024
2016 Q4	$119K	Hold	1,134	–	–	0.01%	989
2016 Q3	$125K	Sell	1,134 -260	-19%	-$34.4K	0.01%	940
2016 Q2	$203K	Hold	1,394	–	–	0.01%	751
2016 Q1	$200K	Buy	+1,394	New	+$198K	0.01%	639

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

LS Investment Advisors's TARO Position: Q4 2017 in Review

LS Investment Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 1,134 shares — an estimated $128K sold.

LS Investment Advisors first reported a position in TARO in Q1 2016 and held it in 7 quarters. The position peaked at $203K in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

LS Investment Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
LS Investment Advisors sold 1,134 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $128K.
LS Investment Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 7 quarters.
LS Investment Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $203K in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on LS Investment Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.